The Latest Breaking News from ABBV

Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 13 unusual trades.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

These three companies all have one thing in common: they are all on sale.

Dividend stocks are attractive for their steady income, stability, and growth potential, especially amid low interest rates and economic uncertainties. Against this backdrop, income-seeking investors may want to consider high-dividend stocks yielding over 3%, such as AbbVie (ABBV), Coca-Cola (KO), and AT&T (T). Keep reading.

Dividend growth stocks offer a unique blend of reliability and growth potential, making them an ideal choice for long-term investors. Therefore, you might consider watching stocks like The Home Depot (HD), AbbVie (ABBV), and McDonald's Corp (MCD) for long-term investments. Read on….

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene (CNC) are well-positioned to meet these needs, making them attractive options for investors seeking to capitalize on the industry’s sustained growth potential. Read…

Despite AbbVie’s outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

As the global population ages, demand for healthcare solutions are expected to surge. As a result, investors might consider fundamentally solid healthcare stocks UnitedHealth Group, AbbVie, and Merck & Co., which are poised to benefit from the aging population boom. Keep reading.

Hunting for value? These three Dividend Aristocrats look cheap by today's valuations.